SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SynAct Pharma Agreement Sets 50/50 Sharing of Brazil Development Costs

The agreement includes equal sharing of development costs for regulatory approval in Brazil.

AB

Related stories